An HIV rapid screening test can provide an important first result, but screening for HIV and establishing a confirmed HIV diagnosis are not the same step.

This distinction is fundamental to safe HIV testing.

A person may receive a Reactive result on an initial HIV rapid test. That result means the screening assay detected the HIV-related marker it was designed to identify.

It does not mean that one rapid-test cassette, by itself, has completed the HIV diagnostic process.

Instead, HIV diagnosis follows an approved testing algorithm involving additional testing with appropriate assays.

This guide explains the difference between HIV screening and confirmatory testing, why multiple tests are used, why repeating the same test is not enough and how a Reactive screening result progresses toward an established HIV status.

What Is an HIV Screening Test?

An HIV screening test is used to identify individuals whose specimens show evidence of the HIV-related marker targeted by that assay.

Depending on the test, this may include:

• Antibodies to HIV-1
• Antibodies to HIV-2
• HIV antibodies together with an HIV antigen such as p24

Screening tests are designed to answer an initial question:

“Does this specimen react in a way that requires further HIV testing?”

They should not automatically be interpreted as answering:

“Has HIV infection been definitively established?”

What Is HIV Confirmatory Testing?

HIV confirmatory testing refers to the additional testing required after an initial Reactive result to establish HIV status according to the applicable national testing algorithm.

This is not simply a matter of looking at the original cassette again.

It involves a defined sequence of appropriate assays selected and validated as part of an HIV testing strategy.

The purpose is to reduce the possibility that an isolated false-reactive screening result is incorrectly reported as HIV infection.

Screening vs Confirmation at a Glance

HIV Screening	HIV Confirmatory / Diagnostic Pathway
Usually begins with an initial HIV assay	Uses additional testing according to an approved algorithm
Identifies Reactive or Non-Reactive screening results	Determines final HIV status according to the testing strategy
A Reactive result requires further evaluation	Multiple appropriately selected assays reduce misdiagnosis
Does not by itself establish HIV infection	Provides the basis for a confirmed diagnostic conclusion

Why Is One Reactive HIV Test Not Enough?

No screening assay has perfect specificity in every testing situation.

Occasionally, a specimen from a person who does not ultimately meet the diagnostic criteria for HIV can still produce a Reactive result on one screening assay.

This is known as a false-reactive result.

Using multiple appropriately selected tests substantially reduces the risk that such a result is incorrectly classified as confirmed HIV infection.

WHO therefore recommends national HIV testing algorithms rather than relying on a single screening assay.

What Does WHO Recommend for HIV Diagnosis?

Current WHO guidance recommends HIV testing algorithms designed to achieve very high diagnostic accuracy.

WHO currently recommends that an HIV-positive diagnosis using serological testing be based on three consecutive Reactive tests within an approved testing algorithm.

This does not mean that someone should simply perform the same cassette three times.

The assays used in the testing strategy must be appropriately selected and verified for their role within the algorithm.

Why Can't the Same HIV Rapid Test Simply Be Repeated Three Times?

Repeating the same test does not provide the same diagnostic assurance as using an approved sequence of appropriately selected assays.

One reason is shared false reactivity.

If the same test technology or the same assay is repeatedly used, the same factor that caused the first false-reactive result may affect subsequent repetitions.

WHO therefore emphasizes careful selection and verification of combinations of HIV assays used in national testing algorithms.

Three repetitions of one cassette ≠ a validated three-test diagnostic algorithm.

What Is an HIV Testing Algorithm?

An HIV testing algorithm is a defined sequence of assays used to determine HIV status.

It specifies:

• Which assay is used first
• What happens after a Non-Reactive result
• What happens after a Reactive result
• Which additional assays are used
• How discordant results are managed
• When HIV-positive status can be reported
• When retesting or further evaluation is required

The algorithm should be based on current national HIV testing guidelines rather than invented by an individual laboratory.

What Happens After the First HIV Screening Test?

The general concept can be understood as:

Initial HIV screening assay
↓
Non-Reactive or Reactive result

If appropriately Non-Reactive:

Further action depends on timing, recent exposure, clinical circumstances and applicable guidance.

If Reactive:

The specimen proceeds to the additional testing required by the applicable HIV testing algorithm.

What Happens After a Reactive Screening Result?

A Reactive initial screening result should lead to:

1. Appropriate counselling and explanation
2. Additional HIV testing according to the national algorithm
3. Resolution of any discordant test results
4. Establishment of final HIV status only after the required testing sequence is completed
5. Linkage to treatment and care if HIV infection is confirmed

A Reactive screening result should never be dismissed, but it should also never be interpreted beyond what the initial assay actually establishes.

What Happens After a Non-Reactive HIV Screening Test?

A Non-Reactive result means the assay did not detect its target HIV marker.

However, interpretation may still require consideration of:

• Timing since possible exposure
• The HIV window period
• The type of assay used
• Whether post-exposure prophylaxis or pre-exposure prophylaxis is relevant
• Clinical circumstances
• Whether repeat testing is recommended

A Non-Reactive test performed too soon after infection may occur before sufficient HIV markers have become detectable.

Read:

HIV Rapid Test: Reactive vs Non-Reactive Results & Why Confirmation Matters

What Are Discordant HIV Test Results?

A discordant result occurs when the assays in an HIV testing sequence do not agree as expected.

For example, one test may be Reactive while a subsequent assay is Non-Reactive.

A discordant pattern should not be resolved by guessing which cassette “looks more convincing.”

Instead, it should be managed according to the applicable HIV testing algorithm, which may require additional testing or retesting after an appropriate interval.

Why Is Discordance Important?

Discordant results can occur for several reasons, including:

• False-reactive screening results
• Very early infection
• Technical or procedural errors
• Specimen-related issues
• Differences between assay technologies
• Other biological factors

The result pattern must therefore be resolved systematically rather than interpreted from one test alone.

Is Western Blot Still Required for HIV Confirmation?

WHO no longer recommends Western blotting or line immunoassays as part of national HIV testing strategies and algorithms.

Modern public-health HIV testing strategies instead use combinations of appropriate serological assays within validated algorithms.

This is important because the phrase “confirm by Western blot” still appears on some older websites and outdated educational material.

Microsidd Knowledge Hub content should therefore avoid automatically telling readers that every Reactive HIV rapid test must be confirmed specifically by Western blot.

What Is Retesting to Verify an HIV-Positive Diagnosis?

WHO also recommends quality-assurance measures intended to reduce the possibility of HIV misdiagnosis.

One important concept is retesting to verify an HIV-positive diagnosis before initiation of lifelong antiretroviral treatment, according to the applicable programme and testing strategy.

This verification step is different from repeatedly screening a person until a desired result appears.

It is a structured quality-assurance measure within HIV services.

Why Is Preventing HIV Misdiagnosis So Important?

Incorrectly diagnosing a person as living with HIV can have serious consequences.

These can include:

• Unnecessary lifelong treatment
• Psychological distress
• Relationship and family consequences
• Unnecessary additional medical investigations
• Loss of trust in healthcare services

Missing true HIV infection also carries serious consequences because it can delay treatment, prevention counselling and appropriate care.

This is why both false-positive misdiagnosis and false-negative classification matter.

What Is the Role of the Microsidd HIV Antibody Rapid Test?

The Microsidd HIV 1 & HIV 2 Antibody Rapid Test Kit is intended for professional HIV antibody screening.

The current product information states:

• Qualitative detection
• HIV-1 and HIV-2 antibodies
• Whole blood, serum or plasma
• Lateral-flow immunochromatographic technology
• Professional in vitro diagnostic use
• Single-use test device

Importantly, the product information explicitly states that:

A Reactive result is not sufficient to establish a diagnosis of HIV infection.

Confirmatory testing should proceed according to applicable national guidelines and laboratory protocols.

Screening Kit vs Diagnostic Algorithm

It is helpful to separate the physical product from the testing programme.

The HIV rapid test kit is one assay.

The HIV testing algorithm is the complete diagnostic strategy.

One assay can form part of the algorithm without representing the entire algorithm.

Why Can't a Manufacturer Claim Replace the National Testing Algorithm?

A manufacturer describes what an individual test is designed to detect and how it performs under validated conditions.

A national HIV programme determines how HIV assays are combined to establish HIV status within that healthcare system.

These are related but different responsibilities.

This is why an HIV kit should be:

Used according to its manufacturer IFU

while the patient's:

HIV status is established according to the applicable national testing algorithm.

India: Follow Current NACO HIV Testing Guidelines

In India, HIV testing services should follow the current guidance of the National AIDS Control Organisation (NACO).

NACO's 2024 National HIV Counselling and Testing Guidelines provide the national framework for HIV counselling, screening, confirmatory testing and linkage to services.

Laboratories and healthcare professionals should therefore use the current NACO algorithm rather than relying on an old diagram copied from the internet or an outdated laboratory manual.

Can a Private Laboratory Create Its Own HIV Confirmation Algorithm?

HIV diagnosis should follow applicable national requirements, regulatory standards and validated testing strategies.

A laboratory should not casually create an improvised sequence such as:

Brand A → Brand A again → Brand A a third time

and call this HIV confirmation.

Testing algorithms require appropriate assay selection, quality assurance and documented procedures.

Is an HIV Self-Test a Confirmatory Test?

No.

A Reactive HIV self-test is a screening result and requires provider-based follow-up testing according to the applicable testing strategy.

An HIV self-test should not be confused with a complete diagnostic algorithm.

Is a Fourth-Generation Test Automatically Confirmatory?

Not simply because it is called fourth generation.

A fourth-generation HIV assay detects both:

• HIV antibodies, and
• An HIV antigen, commonly p24

This can improve early detection compared with antibody-only testing in certain settings, but an individual Reactive assay still must be interpreted according to the applicable diagnostic algorithm.

“Fourth generation” describes assay technology—not permission to ignore the testing algorithm.

Is a PCR or HIV RNA Test Always the Next Test After a Reactive Rapid Test?

Not necessarily.

The appropriate testing pathway depends on:

• National HIV testing guidance
• Patient age
• Clinical circumstances
• Possible acute infection
• The testing technology already used

Do not automatically tell every adult with a Reactive antibody screening test that the required confirmation is “PCR.”

The appropriate next test should follow the applicable HIV diagnostic algorithm.

HIV Antibody Test vs HIV RNA Test

HIV Antibody Test	HIV RNA Test
Detects antibodies generated against HIV	Detects HIV genetic material
Commonly used in HIV screening algorithms	Used for specific diagnostic and clinical purposes
Does not measure viral load unless specifically designed as an RNA quantitative assay—which an antibody test is not	RNA-based testing may be qualitative or quantitative depending on the assay

These are different technologies and should not be treated as interchangeable terms.

HIV Confirmation in Infants Is Different

Standard adult antibody-based testing strategies cannot simply be applied unchanged to young infants.

Maternal HIV antibodies can cross the placenta and remain detectable in an infant for a period after birth.

For this reason, early infant diagnosis relies on appropriate virological testing according to national guidance.

This is another example of why HIV testing algorithms depend on the population being tested.

HIV Screening and Pregnancy

HIV screening is an established part of antenatal infection screening.

If the initial antenatal HIV screening test is Reactive, the pregnant woman should move promptly through the appropriate confirmatory testing pathway.

This matters because early establishment of HIV status allows timely linkage to treatment and interventions designed to support maternal health and reduce vertical transmission.

Continue through the pregnancy pathway:

• Pregnancy Confirmed? First Antenatal Visit & Important Screening Tests
• Antenatal Infection Screening: HIV, Syphilis, Hepatitis B & HCV
• HIV Testing During Pregnancy & Antenatal Care

Screening, Confirmation and Viral Load Are Three Different Concepts

These terms are frequently confused.

Process	Main Purpose
HIV screening	Identify whether an HIV marker is detected and whether additional testing is required.
HIV diagnostic algorithm	Establish HIV status using the required sequence of appropriately selected assays.
HIV viral-load testing	Measure HIV RNA for appropriate clinical purposes, particularly monitoring treatment response and viral suppression.

A rapid screening cassette does not provide a viral load.

Screening, Confirmation and CD4 Testing Are Also Different

A CD4 test measures a population of immune cells.

It is not a substitute for HIV screening and does not serve as the diagnostic confirmation of a Reactive rapid antibody test.

Therefore:

HIV screening test ≠ HIV diagnostic algorithm ≠ Viral load ≠ CD4 count.

Common Myths About HIV Confirmation

Myth 1: Two lines on one HIV rapid test confirm HIV.

Not by themselves. They may indicate a Reactive screening result according to that assay's IFU, but final HIV status requires the applicable testing algorithm.

Myth 2: Performing the same rapid test three times confirms HIV.

No. Repeating one assay is not equivalent to using the appropriately selected assays in a validated testing algorithm.

Myth 3: Every Reactive HIV test must be confirmed by Western blot.

Outdated. WHO recommends that countries move away from Western blotting and line immunoassays in national HIV testing algorithms.

Myth 4: A fourth-generation test never needs additional testing.

Incorrect. A Reactive result still requires interpretation through the appropriate diagnostic algorithm.

Myth 5: A very dark test line means HIV is definitely confirmed.

Incorrect. Line intensity does not replace confirmatory testing and does not measure viral load.

Myth 6: A Reactive test can identify who transmitted HIV.

No. A rapid-test result cannot determine who transmitted the infection, when transmission occurred or the route of transmission.

The Correct HIV Testing Concept

The safest way to remember HIV testing is:

SCREEN
Initial HIV assay

↓

REACTIVE?
Further testing is required

↓

FOLLOW THE NATIONAL HIV TESTING ALGORITHM
Appropriately selected additional assays

↓

ESTABLISH HIV STATUS

↓

LINK TO APPROPRIATE CARE

Frequently Asked Questions

What is the difference between HIV screening and confirmation?

Screening is the initial testing step used to identify a Reactive or Non-Reactive result. Confirmation involves additional testing according to an approved HIV testing algorithm before HIV-positive status is established.

Can one HIV rapid test confirm HIV?

No. A single Reactive rapid screening test should not by itself be regarded as a confirmed HIV-positive diagnosis.

Why are additional HIV tests required?

Additional appropriately selected assays reduce the risk of false-positive misdiagnosis and allow final HIV status to be established with high accuracy.

Does WHO recommend three tests for HIV diagnosis?

Current WHO guidance recommends three consecutive Reactive serological tests within an approved HIV testing algorithm to provide an HIV-positive diagnosis. This means appropriately selected assays—not simply repeating the same cassette three times.

What HIV testing guidelines apply in India?

Healthcare professionals and testing services in India should follow the current National HIV Counselling and Testing Guidelines issued by NACO and other applicable national requirements.

Is repeating the same HIV test confirmation?

No. Repeating the same screening assay is not equivalent to following a validated multi-assay HIV testing algorithm.

Is Western blot required after every Reactive HIV test?

No. WHO recommends moving away from Western blot and line immunoassays in national HIV testing algorithms. Follow the current applicable national algorithm instead.

Does a Reactive fourth-generation test confirm HIV?

No single Reactive assay should automatically be regarded as the complete HIV diagnostic pathway. Follow the applicable testing algorithm.

Does HIV confirmation mean viral-load testing?

Not necessarily. HIV diagnosis and viral-load monitoring are different processes. The appropriate diagnostic tests depend on the applicable HIV testing algorithm.

Does the Microsidd HIV rapid test confirm HIV?

No. The Microsidd HIV 1 & HIV 2 Antibody Rapid Test Kit is intended for professional qualitative HIV antibody screening. The product information itself states that a Reactive result is insufficient to establish an HIV diagnosis.

What should happen after a Reactive Microsidd HIV antibody test?

The individual should be linked to appropriate HIV counselling and additional testing according to the applicable national testing algorithm.

What if the first HIV test is Reactive and the next test is Non-Reactive?

This is a discordant testing pattern and should be managed according to the applicable HIV testing algorithm. Do not decide final status from either result in isolation.

Is HIV confirmation different for babies?

Yes. Young infants require appropriate virological testing because maternal antibodies can affect antibody-based testing. Follow national early-infant-diagnosis guidance.

Continue Through the Microsidd HIV Rapid Testing Hub

• HIV Rapid Test Kit Complete Guide
• How to Use an HIV Rapid Test Kit
• HIV Rapid Test: Reactive vs Non-Reactive Results
• HIV Rapid Test Do's, Don'ts & Common Errors
• HIV Rapid Test Storage & Expiry Guide
• HIV Testing During Pregnancy & Antenatal Care

Microsidd HIV 1 & HIV 2 Antibody Rapid Test Kit

Healthcare professionals and diagnostic laboratories can view the professional screening product here:

Microsidd HIV 1 & HIV 2 Antibody Rapid Test Kit

The product provides qualitative HIV-1 and HIV-2 antibody screening using whole blood, serum or plasma and should be used according to its exact Instructions for Use.

A Reactive result from this product is a screening result and must not independently be treated as a confirmed HIV diagnosis.

Medical Information Notice

This article is intended for general educational and professional product-information purposes. It does not replace the current NACO HIV testing guidelines, the manufacturer's Instructions for Use, HIV counselling, laboratory standard operating procedures or medical evaluation.

HIV testing strategies and algorithms may be updated as evidence and national programmes evolve. Healthcare professionals should follow the current applicable national testing algorithm rather than relying on an outdated testing diagram or a single rapid-test result.

A single Reactive HIV screening test does not establish a confirmed HIV diagnosis. Appropriate additional testing must be performed according to the applicable HIV testing strategy.

Anyone receiving a Reactive, discordant, unexpected or otherwise concerning HIV screening result should receive appropriate professional counselling, testing and follow-up.